A Phase 1, Randomized, Double-blinded, Four-period Crossover, Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 13 May 2019
Price : $35 *
At a glance
- Drugs Zoliflodacin (Primary) ; Moxifloxacin
- Indications Gonorrhoea
- Focus Adverse reactions
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 06 Dec 2018 Planned End Date changed from 23 Dec 2018 to 6 Jan 2019.
- 06 Dec 2018 Planned primary completion date changed from 23 Dec 2018 to 6 Jan 2019.